CanNegev will be operated for the Israel Innovation Authority (IIA), an agency of the Economy and Industry Ministry, by a consortium made up of global investment platform OurCrowd; Perrigo, the world’s largest non-prescription drug company; and Israeli medical cannabis company BOL Pharma, an OurCrowd portfolio company.

Read more here.